NDC properties for NDC 9 70114-220
NDC item 70114022002
| NDC 9 | 70114-220 |
|---|---|
| NDC 10 | 70114-220-02 |
| NDC Item | 70114022002 |
| packaging | 2 SYRINGE, GLASS in 1 CARTON (70114-220-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761216 |
| Labeler | Coherus BioSciences Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 71288081580
| NDC 9 | 71288-815 |
|---|---|
| NDC 10 | 71288-815-80 |
| NDC Item | 71288081580 |
| BLA | BLA761216 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 71288081581
| NDC 9 | 71288-815 |
|---|---|
| NDC 10 | 71288-815-81 |
| NDC Item | 71288081581 |
| packaging | 2 SYRINGE, GLASS in 1 CARTON (71288-815-81) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761216 |
| Labeler | Meitheal Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |